4.8 Article

Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma

Chetan Bettegowda et al.

SCIENCE (2011)

Review Clinical Neurology

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

Michael Weller et al.

NATURE REVIEWS NEUROLOGY (2010)

Review Oncology

Genetic alterations and signaling pathways in the evolution of gliomas

Hiroko Ohgaki et al.

CANCER SCIENCE (2009)

Article Clinical Neurology

Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches

Markus J. Riemenschneider et al.

CURRENT OPINION IN NEUROLOGY (2009)

Article Biochemistry & Molecular Biology

Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity

Juxiang Cao et al.

EMBO JOURNAL (2009)

Review Biotechnology & Applied Microbiology

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Dunyaporn Trachootham et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Review Clinical Neurology

The 2007 WHO classification of tumours of the central nervous system

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2007)

Article Biochemistry & Molecular Biology

Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines

Ji-Yeon Bae et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2007)

Article Clinical Neurology

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss

Constance A. Griffin et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)

Article Biochemistry & Molecular Biology

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

M Hermisson et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Oncology

Adjuvant treatment of high grade gliomas

M. J. van den Bent

ANNALS OF ONCOLOGY (2006)

Review Biochemistry & Molecular Biology

Peroxiredoxins, oxidative stress, and cell proliferation

S Immenschuh et al.

ANTIOXIDANTS & REDOX SIGNALING (2005)

Article Medicine, General & Internal

MGMT gene silencing and benefit from temozolomide in glioblastoma

ME Hegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Clinical Neurology

Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology

G Reifenberger et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)

Article Pathology

Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age

A Korshunov et al.

AMERICAN JOURNAL OF PATHOLOGY (2003)

Article Biochemistry & Molecular Biology

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer

SB Baylin et al.

HUMAN MOLECULAR GENETICS (2001)